Is Davide Campari-Milano (BIT:CPR) Undervalued On Weaker Half Year 2026 Earnings?
Davide Campari-Milano (BIT:CPR) shares are in focus after the company reported half-year 2026 earnings. Sales were €1,512 million and net income was €129 million, both lower than the prior-year period.
See our latest analysis for Davide Campari-Milano.
Following the half year 2026 results, Davide Campari-Milano shares have seen a 1-month share price return of 8.07% and a 7.37% share price return year to date, although the 3-year total shareholder return has declined 49.85%. This suggests that recent momentum contrasts with weaker longer term outcomes.
If earnings volatility has you reassessing your watchlist, this could be a good moment to seek fresh ideas using our screener of 106 top founder-led companies
Davide Campari-Milano now trades at a double digit discount to both analyst targets and an estimated fair value, even after the recent rebound. Does that gap reflect an opportunity, or is it a fair response to softer earnings?
Most Popular Narrative: 16.3% Undervalued
On the latest numbers, Davide Campari-Milano closed at €5.92 compared with a narrative fair value estimate of about €7.06, which points to a valuation gap that analysts are trying to explain through their long term earnings framework.
Analysts expect earnings to reach €467.3 million (and earnings per share of €0.39) by about March 2029, up from €346.3 million today. However, there is a considerable amount of disagreement amongst the analysts with the most bullish expecting €555.8 million in earnings, and the most bearish expecting €407.1 million.
Want to understand why Davide Campari-Milano might support a richer future P/E and higher margins? The narrative leans on measured revenue growth, fatter profitability and a higher earnings multiple years from now. Curious which assumptions really carry that fair value and how much is tied to earnings versus margins and discount rate shifts? The full narrative lays out the numbers that sit behind that €7.06 figure.
Result: Fair Value of €7.06 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, Davide Campari-Milano still faces meaningful risks, including potential tariff and currency pressure on margins, and heavy reliance on core brands that could test this upbeat narrative.
Find out about the key risks to this Davide Campari-Milano narrative.
Another View: What Davide Campari-Milano’s P/E Is Telling You
The fair value at €7.06 suggests Davide Campari-Milano is undervalued, yet its current P/E of 20.5x sits above both the European Beverage industry at 19.2x and a fair ratio of 14.8x. That gap points to valuation risk if sentiment or growth expectations cool.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
If this mix of risks and rewards around Davide Campari-Milano feels finely balanced, take a moment to review the data and decide where you stand. To see a concise summary of both sides of the argument, start with these 4 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Davide Campari-Milano?
If Davide Campari-Milano has you rethinking your positioning, use this moment to widen your search and stress test your portfolio with new, high quality ideas.
- Target resilience and lower volatility by scanning companies that appear in our 304 resilient stocks with low risk scores to see which stocks might help steady your overall returns.
- Explore potential mispricings by reviewing our source of 249 high quality undervalued stocks and see which businesses currently trade below their assessed worth.
- Look for potential tomorrow's leaders early by checking the screener containing 518 high quality undiscovered gems before other investors pay closer attention.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com